Seminar Videos

 

The Role of Interferon Gamma Release Assay for the Diagnosis of Latent Tuberculosis Infection in Immunocompromised Host

Dr. Hidetoshi Igari M.D., PhD
Associate Professor, Chairman of Division of Infection Control, Chiba University Hospital

 

An Overview of the “Latent Tuberculosis Infection therapy guideline” – focused on the at- high-risk populations to progress

Dr. Seiya Kato M.D., PhD
Director of the Research Institute of Tuberculosis, Japan Anti- Tuberculosis Association

 

IGRA for the TB infection Control

Dr. Katsuhiro Suzuki M.D., PhD
General Manager of the Medical Treatment Division, Respiratory MedicineNational Hospital Organization Kinki-Chuo Chest Medical Center

 

Interpretation of IGRA results for pulmonary disease

Dr. Kiyoyasu Fukushima M.D., PhD
Vice-director of Japanese Red Cross Nagasaki Genbaku Hospital

 

 

Product claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.

お問い合わせ
Follow QIAGEN on: